Global food giants Nestlé and Danone are facing mounting pressure from investors and regulators to disclose the financial consequences of sweeping infant formula recalls that have rattled their reputations and reportedly left dozens of babies ill. The developments, detailed in reporting by Reuters, mark one of the most serious food-safety challenges to hit the sector in recent years.
Nestlé began recalling products in December across Europe, Asia, and the Americas after concerns that some batches could be contaminated with cereulide, a toxin known to cause nausea and vomiting. The crisis prompted a public video apology from the company’s new chief executive, Philipp Navratil, and quickly spread to involve other manufacturers, including Danone and privately held dairy group Lactalis.
French authorities have since opened investigations into how the recalls were handled, while consumers and shareholders question whether companies acted quickly and transparently enough. Investors are now looking for detailed explanations of the financial damage as the companies present their annual results, with some analysts warning that the long-term commercial impact could exceed initial estimates.
Portfolio managers such as those at Flossbach von Storch have criticized what they describe as limited communication during the crisis, saying clearer disclosures are needed to rebuild confidence. Industry specialists, including analysts at RaboResearch, stress that trust is particularly critical in the infant nutrition market, where brand credibility can determine purchasing decisions for years.
The contamination has been traced by French investigators to ingredients supplied by Chinese manufacturer Cabio Biotech, prompting affected producers to switch suppliers and reconfigure production chains. The scramble to secure alternative sources has added operational strain and heightened scrutiny of global supply networks.
Danone may be more vulnerable to lasting financial effects because infant formula represents a significant share of its profits in China, a market historically sensitive to food-safety scandals. Nestlé, while less dependent on the category, risks setbacks to one of its stronger-performing nutrition brands as it simultaneously battles slower growth and increased competition from lower-cost alternatives.
Rival manufacturers are already seeing shifts in demand. Germany’s family-owned HiPP has reported a surge in orders as parents switch brands, while New Zealand-based a2 Milk said it does not yet expect a major sales windfall.
Analysts warn that beyond direct recall costs, both companies face potential losses in market share and prolonged reputational damage. For leadership at Nestlé, the episode adds another test as management attempts to revive growth while navigating tariff pressures and changing consumer behavior. The broader lesson for the industry, experts say, is that in infant nutrition even a limited safety scare can quickly escalate into a global crisis with lasting financial and emotional consequences.